Generic Name and Formulations:
Isosulfan blue 10mg/mL; soln for SC inj; preservative-free.
Indications for LYMPHAZURIN:
An adjunct to lymphography (in primary and secondary lymphedema of the extremities; chyluria, chylous ascites or chylothorax; lymph node involvement by primary or secondary neoplasm; and lymph node response to therapeutic modalities) for visualization of the lymphatic system draining the region of injection.
Give by SC inj. 0.5mL into 3 interdigital spaces of each extremity per study. Max dose 3mL (30mg).
Hypersensitivity to triphenylmethane.
Have emergency equipment available for at least 30–60 minutes after injection. Urine color may be blue for 24hrs post administration. Pregnancy (Cat.C). Nursing mothers.
Do not mix with local anesthetics (eg, lidocaine) in the same syringe; precipitation results.
Local reactions, pruritus; anaphylaxis possible.
Single-dose vial (5mL)—1
Clinical Pain Advisor Articles
- Brain Plasticity in Patients With Complex Regional Pain Syndrome
- Perturbation-Based Rehabilitation Effective for Chronic Low Back Pain
- IBS-Associated Chronic Pain: Formulation of Core Diagnostic Criteria
- Fluoroscopically Guided Sacroiliac Interventions: Appropriate Use Criteria
- Cannabis Use Associated With Relationship Between Pain and Negative Affect
- Cannabis Use Associated With Aberrant Drug Behaviors
- Walgreens to Carry Naloxone in All Pharmacies to Combat Drug Abuse
- Independent Pharmacies Expanding Services Available to Patients
- Ketamine Exhibits Effective Pain Relief for Refractory Headaches
- Pain In Elite Athletes: IOC Recommendations on Contributing Factors and Treatment Approach
- Naproxen Plus Muscle Relaxants vs Naproxen Monotherapy for Low Back Pain
- Pain Processing: Examining the Role of Oxytocin
- Short- vs Long-Acting Opioids for Osteoarthritis Pain
- Extended-Release Naltrexone Injections Reduce Opioid Dependence
- Depressive Symptoms in Medical Interns Increased With Work-Family Conflicts